Recently, the New Zealand patent application "PTH prodrugs" – a global counterpart patent application filed and owned by Ascendis Pharma Growth Disorders AG, with the theme "PTH prodrugs" – has been granted. Previously, two patents in this same family had been granted in Australia, and one patent each had been granted in China, Japan, South Korea, Russia, South Africa, Malaysia, Hong Kong SAR, China, and Macao SAR, China.

Beijing Caihe Law Firm was entrusted by Ascendis Pharma Growth Disorders AG to provide full-cycle consulting services for some cases in this counterpart patent application.